Etheros Pharmaceuticals Corp. — Form D
Etheros Pharmaceuticals Corp. of NASHVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-20. The offering totals $300K, of which $300K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-12-20
- Form: D
- Accession: 0001839882-23-034241
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $300K
- Minimum investment: $60K
- Investors: 2
- Date of first sale: 2023-11-06
- Revenue range: Decline to Disclose
- SEC file number: 021-500244
Issuer
- Name: Etheros Pharmaceuticals Corp.
- CIK: 0002005132
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 111 10TH AVE S, NASHVILLE, TN, 37203
- Phone: 615-212-9695
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Francis William Knuettel | Director | Nashville, TN |
| Subhasish William Chakraborty | Executive Officer | Nashville, TN |
| John William Scannell | Director | Nashville, TN |
| John William Scannell | Executive Officer | Nashville, TN |
| Marc William Feldmann | Director | Nashville, TN |
| Francis William Knuettel II | Director | Nashville, TN |
| Laura William Dugan | Director | Nashville, TN |
Other filings by this issuer (2)
More